Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Vancomycin for Infection Prophylaxis in Total Hip and Knee Arthroplasty
NCT04993027Phase 2Not yet recruiting
- Sponsor
- Alberta Hip and Knee Clinic
- Start
- Dec 2025
- Primary completion
- Dec 2028
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
A Phase 2 trial of vancomycin in periprosthetic joint infection (PJI), sponsored by Alberta Hip and Knee Clinic. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
vancomycin
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT04993027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04993027.